Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

Mutation and cancer: statistical study of retinoblastoma

Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612

Untitled work

(1968) · Medical Entomology and Zoology · Cited by 4,924

Manipulating the mouse embryo: A laboratory manual

Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460

Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells

Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355

Simplified mammalian DNA isolation procedure

Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. J. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,497

Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients

Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J. M., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,478

Von Recklinghausen Neurofibromatosis

Riccardi, V. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052704 · Cited by 1,353

Neural Crest Cells Contribute to Normal Aorticopulmonary Septation

Kirby, M. L., Gale, T. F., & Stewart, D. E. (1983) · Science · doi:10.1126/science.6844926 · Cited by 1,118

The neurofibromatosis type 1 gene encodes a protein related to GAP

Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus

Viskochil, D. H., Buchberg, A. M., Xu, G., Cawthon, R., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082

Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study

Leppävirta, J., Kallionpää, R. A., Uusitalo, E., Vahlberg, T. J., Pöyhönen, M., Peltonen, J. T. K., & Peltonen, S. A. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0756-4 · Cited by 31

Zebrafish Cancer Predisposition Models

Kobar, K., Collett, K., Prykhozhij, S. V., & Berman, J. N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660069 · Cited by 34

Neurofibromatosis Type 1 Alternative Splicing Is a Key Regulator of Ras Signaling in Neurons

Hinman, M. N., Sharma, A., Luo, G., & Lou, H. J. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00019-14 · Cited by 31

Ras-Related Signaling Pathways in Valve Development: Ebb and Flow

Yutzey, K. E., Colbert, M. C., & Robbins, J. M. (2005) · Physiology · doi:10.1152/physiol.00035.2005 · Cited by 31

Deterioration of fracture healing in the mouse model of NF1 long bone dysplasia

Khassawna, T. E., Toben, D., Kolanczyk, M., Schmidt‐Bleek, K., Könnecke, I., Schell, H., Mundlos, S., & Duda, G. N. (2012) · Bone · doi:10.1016/j.bone.2012.07.011 · Cited by 30

Mice with missense and nonsense NF1 mutations display divergent phenotypes compared to NF1 patients

Li, K., Turner, A. N., Chen, M., Brosius, S. N., Schoeb, T. R., Messiaen, L. M., Bedwell, D. M., Zinn, K. R., Anastasaki, C., Gutmann, D. H., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.025783 · Cited by 30

Regulation of Ras signal transduction during T cell development and activation.

Lapinski, P. E., & King, P. D. (2012) · PubMed Central · Cited by 30

Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype

Kamiya, N., Yamaguchi, R., Aruwajoye, O. O., Kim, A. J., Kuroyanagi, G., Phipps, M. C., Adapala, N. S., Feng, J. Q., & Kim, H. K. W. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3155 · Cited by 30

Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice

Nguyen, H. T. M., Hinman, M. N., Guo, X., Sharma, A., Arakawa, H., Luo, G., & Lou, H. J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx264 · Cited by 29

Vcp Overexpression and Leucine Supplementation Increase Protein Synthesis and Improve Fear Memory and Social Interaction of Nf1 Mutant Mice

Shih, Y., Huang, T., Hu, H., Yen, T., & Hsueh, Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107835 · Cited by 26

Renal Manifestations of Tuberous Sclerosis Complex

Torres, V. E., Zincke, H., King, B., & Björnsson, J. (1997) · KARGER eBooks · doi:10.1159/000059871 · Cited by 29

Cardiac Morphogenesis and Dysmorphogenesis: An Immunohistochemical Approach

Waller, B. R., & Wessels, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-685-1:151 · Cited by 29

Review Article : Neurofibromin in the Brain

Gutmann, D. H. (2002) · Journal of Child Neurology · doi:10.1177/088307380201700809 · Cited by 28

NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma

Solga, A. C., Gianino, S. M., & Gutmann, D. H. (2013) · Oncogene · doi:10.1038/onc.2012.580 · Cited by 28

RasGAPs: a crucial regulator of extracellular stimuli for homeostasis of cellular functions

Iwashita, S., & Song, S. (2008) · Molecular BioSystems · doi:10.1039/b716357f · Cited by 28

Transgenic assays for mutations and cancer: current status and future perspectives

Vijg, J., & STEEG, H. V. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00030-x · Cited by 28

Cardiac transgenic and gene-targeted mice as models of cardiac hypertrophy and failure: A problem of (new) riches

Izumo, S., & Shioi, T. (1998) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(98)90231-7 · Cited by 28

Angelman syndrome in adulthood

Laan, L., den Boer, A. T., Hennekam, R. C. M., Renier, W. O., & Brouwer, O. F. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19961218)66:3 · Cited by 140

Motivational Disturbances and Effects of L-dopa Administration in Neurofibromatosis-1 Model Mice

Wozniak, D. F., Diggs‐Andrews, K. A., Conyers, S. B., Yuede, C. M., Dearborn, J. T., Brown, J. A., Tokuda, K., Izumi, Y., Zorumski, C. F., & Gutmann, D. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066024 · Cited by 27

Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening

Kraniak, J. M., Chalasani, A., Wallace, M. R., & Mattingly, R. R. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.012 · Cited by 27

An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors

Patel, A. V., Chaney, K. E., Choi, K., Largaespada, D. A., Kumar, A. R., & Ratner, N. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.007 · Cited by 28

Malignant Peripheral Nerve Sheath Tumors

Durbin, A. D., Ki, D. H., He, S., & Look, A. T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-30654-4_22 · Cited by 27

Molecular and cellular mechanisms of cognitive function: implications for psychiatric disorders

Silva, A. J., Elgersma, Y., & Costa, R. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00294-2 · Cited by 26

Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice

Feigenbaum, L., Fujita, K., Collins, F. S., & Jay, G. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3280-3285.1996 · Cited by 26

In Vivo Regulation of TGF-β by R-Ras2 Revealed through Loss of the RasGAP Protein NF1

Patmore, D. M., Welch, S., Fulkerson, P. C., Wu, J., Choi, K., Eaves, D. W., Kordich, J. J., Collins, M. H., Cripe, T. P., & Ratner, N. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1972 · Cited by 26

Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts inNf1 knockout mice

Wu, M. H., Wallace, M. R., & Muir, D. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20646 · Cited by 26

From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation

Hsueh, Y. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-33 · Cited by 25

Regulated expression of neurofibromin in migrating neural crest cells of avian embryos

Stocker, K. M., Baizer, L., Coston, T., Sherman, L. S., & Ciment, G. (1995) · Journal of Neurobiology · doi:10.1002/neu.480270408 · Cited by 26

Monozygotic Twins with Chromosome 22q11 Microdeletion and Discordant Phenotypes in Cardiovascular Patterning

Lu, J., Chung, M., Hwang, B., & Chien, H.-P. (2001) · Pediatric Cardiology · doi:10.1007/s002460010219 · Cited by 26

Murine Mentors: Transgenic and Knockout Models of Surgical Disease

Arbeit, J. M., & Hirose, R. (1999) · Annals of Surgery · doi:10.1097/00000658-199901000-00004 · Cited by 26

Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis

Brosius, S. N., Turk, A. N., Byer, S. J., Brossier, N. M., Kohli, L., Whitmire, A., Mikhail, F. M., Roth, K. A., & Carroll, S. L. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1209-3 · Cited by 25

MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model

Tidyman, W. E., Goodwin, A. F., Maeda, Y., Klein, O. D., & Rauen, K. A. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049166 · Cited by 25

β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice

Kim, A., Morgan, K. J., Hasz, D. E., Wiesner, S. M., Lauchle, J., Geurts, J. L., Diers, M. D., Le, D., Kogan, S. C., Parada, L. F., et al. (2006) · Blood · doi:10.1182/blood-2006-05-025395 · Cited by 25

Schwann Cell Preparation from Single Mouse Embryos: Analyses of Neurofibromin Function in Schwann Cells

Ratner, N., Williams, J. P., Kordich, J. J., & Kim, H. A. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07003-5 · Cited by 25

Transgenic and gene disruption techniques in the study of neurocarcinogenesis

Aguzzi, A., Brandner, S., Isenmann, S., Steinbach, J. P., & Sure, U. (1995) · Glia · doi:10.1002/glia.440150314 · Cited by 25

Tumor Suppressor Mutations and Growth Factor Signaling in the Pathogenesis of NF1-Associated Peripheral Nerve Sheath Tumors. I. The Role of Tumor Suppressor Mutations

Carroll, S. L., & Stonecypher, M. S. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.11.1115 · Cited by 25

GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype

Bahuau, M. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.638 · Cited by 24

NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma

Mahalingam, M. (2016) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000131 · Cited by 24

Plexiform‐like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor‐derived Schwann cell line

Perrin, G. Q., Fishbein, L. M., Thomson, S. A. M., Thomas, S. L., Stephens, K. G., Garbern, J. Y., DeVries, G. H., Yachnis, A. T., Wallace, M. R., & Muir, D. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21226 · Cited by 24

Neurofibromin, the Neurofibromatosis Type 1 Ras‐GAP, Is Required for Appropriate P0 Expression and Myelination

Rosenbaum, T., Kim, H. A., Boissy, Y. L., LING, B., & Ratner, N. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08583.x · Cited by 24

Neurofibromatosis and Associated Tumour Suppressor Genes

Zwarthoff, E. C. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80086-0 · Cited by 24

Mechanisms of carcinogenesis and the mutant mouse

Williams, B. O., & Jacks, T. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90012-x · Cited by 24

Mouse models of neurofibromatosis

McClatchey, A. I., & Cichowski, K. M. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00026-3 · Cited by 23

A man, a syndrome, a gene: Clouston's hidrotic ectodermal dysplasia (HED)

Fraser, F. C., & Kaloustian, V. M. D. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20010422)100:2 · Cited by 24

Gene-Targeted Deletion of Neurofibromin Enhances the Expression of a Transient Outward K+Current in Schwann Cells: A Protein Kinase A-Mediated Mechanism

Xu, Y., Chiamvimonvat, N., Vázquez, A. E., Akunuru, S., Ratner, N., & Yamoah, E. N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09194.2002 · Cited by 23

Loss of neurofibromatosis-1 and p19ARF cooperate to induce a multiple tumor phenotype

King, D., Yang, G., Thompson, M. A., & Hiebert, S. W. (2002) · Oncogene · doi:10.1038/sj.onc.1205632 · Cited by 23

Neurofibromatosis and related tumors. Natural occurrence and animal models.

Riccardi, V. M., Womack, J. E., & Jacks, T. (1994) · PubMed Central · Cited by 23

An Effector-like Function of Ras GTPase-activating Protein Predominates in Cardiac Muscle Cells

Abdellatif, M., & Schneider, M. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.525 · Cited by 23

Functional and morphological cardiovascular alterations associated with neurofibromatosis 1

Cutruzzolà, A., Irace, C., Frazzetto, M., Sabatino, J., Gullace, R., Rosa, S. D., Spaccarotella, C., Concolino, D., Indolfi, C., & Gnasso, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-68908-0 · Cited by 22

Tissue culture methods to study neurological disorders: Establishment of immortalized Schwann cells from murine disease models

Watabe, K., Sakamoto, T., Kawazoe, Y., Michikawa, M., Miyamoto, K., Yamamura, T., Saya, H., & Araki, N. (2003) · Neuropathology · doi:10.1046/j.1440-1789.2003.00478.x · Cited by 22

Role of NF2 Haploinsufficiency in NF2‐associated Polyneuropathy

Hanemann, C. O., Diebold, R., & Kaufmann, D. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00086.x · Cited by 22

Perinatal Epidermal Growth Factor Receptor Blockade Prevents Peripheral Nerve Disruption in a Mouse Model Reminiscent of Benign World Health Organization Grade I Neurofibroma

Wu, J., Crimmins, J. T., Monk, K. R., Williams, J. P., Fitzgerald, M. E., Tedesco, S., & Ratner, N. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050859 · Cited by 22

The Neurofibromatosis Type 1 (Nf1) Tumor Suppressor is a Modifier of Carcinogen-Induced Pigmentation and Papilloma Formation in C57BL/6 Mice

Atit, R. P., Mitchell, K. R., Nguyen, L., Warshawsky, D., & Ratner, N. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00994.x · Cited by 22

Therapeutic Efficacy of G207 in a Novel Peripheral Nerve Sheath Tumor Model

Mashour, G. A., Moulding, H. D., Chalavi, A., Khan, G., Rabkin, S. D., Martuza, R. L., Driever, P. H., & Kurtz, A. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7641 · Cited by 22

Retroviral Integration at the Epi1 Locus Cooperates with Nf1 Gene Loss in the Progression to Acute Myeloid Leukemia

Blaydes, S. M., Kogan, S. C., Truong, B.-T., Gilbert, D. J., Jenkins, N. A., Copeland, N. G., Largaespada, D. A., & Brannan, C. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9427-9434.2001 · Cited by 22

Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis type 1

Ma, J., Li, M., Hock, J. M., & Yu, X. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21497 · Cited by 22

Modeling RASopathies with Genetically Modified Mouse Models

Hernández-Porras, I., & Guerra, C. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6424-6_28 · Cited by 22

Assessment of nociception and related quality-of-life measures in a porcine model of neurofibromatosis type 1

Khanna, R., Moutal, A., White, K. A., Chefdeville, A., de Assis, P. N., Cai, S., Swier, V. J., Bellampalli, S. S., Giunta, M. D., Darbro, B. W., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001648 · Cited by 21

Overactivation of Ras signaling pathway in CD133+ MPNST cells

Borrego-Diaz, E., Terai, K., Lialyte, K., Wise, A. L., Esfandyari, T., Behbod, F., Mautner, V. F., Spyra, M., Taylor, S. A., Parada, L. F., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0852-1 · Cited by 21

Dynamic expression patterns of leucine‐rich repeat containing protein 10 in the heart

Kim, K., Kim, T., Micales, B. K., Lyons, G. E., & Lee, Y. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21225 · Cited by 21

Fluorescently Labelled Guanine Nucleotide Binding Proteins to Analyse Elementary Steps of GAP-catalysed Reactions

Kraemer, A., Brinkmann, T., Plettner, I., Goody, R. S., & Wittinghofer, A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01136-1 · Cited by 21

The association of neurofibromatosis 1 and spinal deformity with primary hyperparathyroidism and osteomalacia: might melatonin have a role?

Abdel-Wanis, M. E.-S., Kawahara, N., & Tomita, K. (2001) · Journal of Orthopaedic Science · doi:10.1007/s007760100071 · Cited by 21

A novel mutation in the endothelin B receptor gene in a patient with Shah-Waardenburg syndrome and Down syndrome

Boardman, J. P., Syrris, P., Holder, S. E., Robertson, N. J., Carter, N., & Lakhoo, K. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.646 · Cited by 21

Temporally and spatially restricted expression of apolipoprotein J in the developing heart defines discrete stages of valve morphogenesis

Witte, D. P., Aronow, B. J., Dry, J. K., & Harmony, J. A. K. (1994) · Developmental Dynamics · doi:10.1002/aja.1002010311 · Cited by 21

Neurofibromatosis Type 1: Genetic and Cellular Mechanisms of Peripheral Nerve Tumor Formation

Rosenbaum, T., Patrie, K. M., & Ratner, N. (1997) · The Neuroscientist · doi:10.1177/107385849700300614 · Cited by 21

JNK inhibitors increase osteogenesis in Nf1-deficient cells

Sullivan, K., El‐Hoss, J., Little, D. G., & Schindeler, A. (2011) · Bone · doi:10.1016/j.bone.2011.09.043 · Cited by 20

Definition of germ layer cell lineage alternative splicing programs reveals a critical role for Quaking in specifying cardiac cell fate

Fagg, W. S., Liu, N., Braunschweig, U., de Castro, K. L. P., Chen, X., Ditmars, F. S., Widen, S. G., Donohue, J. P., Módis, K., Russell, W. K., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac327 · Cited by 21

Snrpb is required in murine neural crest cells for proper splicing and craniofacial morphogenesis

Alam, S. S., Kumar, S., Beauchamp, M.-C., Bareke, E., Boucher, A., Nzirorera, N., Dong, Y., Padilla, R., Zhang, S. J., Majewski, J., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049544 · Cited by 20

Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1

Freret, M. E., & Gutmann, D. H. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24250 · Cited by 20

Longitudinal phenotype development in a minipig model of neurofibromatosis type 1

Uthoff, J., Larson, J., Sato, T. S., Hammond, E., Schroeder, K. E., Rohret, F., Rogers, C. S., Quelle, D. E., Darbro, B. W., Khanna, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61251-4 · Cited by 20

Neurofibromin signaling and synapses

Hsueh, Y. (2007) · Journal of Biomedical Science · doi:10.1007/s11373-007-9158-2 · Cited by 21

Neurofibromatosis type 1

Parada, L. F. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00014-7 · Cited by 20

Gene knockout and transgenic technologies in risk assessment: The next generation

Rosenberg, M. P. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199711)20:3 · Cited by 20

Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1

Osum, S. H., Watson, A. L., & Largaespada, D. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041954 · Cited by 19

Pediatric low-grade glioma models: advances and ongoing challenges

Yvone, G. M., & Breunig, J. J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1346949 · Cited by 19

Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos

Yzaguirre, A. D., Padmanabhan, A., de Groh, E. D., Engleka, K. A., Li, J., Speck, N. A., & Epstein, J. A. (2015) · eLife · doi:10.7554/elife.07780 · Cited by 19

Neurofibromin Negatively Regulates Neurotrophin Signaling through p21ras in Embryonic Sensory Neurons

Vogel, K. S., El-Afandi, M. C. T., & Parada, L. F. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0836 · Cited by 19

Mouse Models of Human Familial Cancer Syndromes

Ward, J. M., & Devor-Henneman, D. E. (2004) · Toxicologic Pathology · doi:10.1080/01926230490424680 · Cited by 19

The Ras GTPase-activating protein neurofibromin 1 promotes the positive selection of thymocytes

Oliver, J. A., Lapinski, P. E., Lubeck, B. A., Turner, J. S., Parada, L. F., Zhu, Y., & King, P. D. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.03.005 · Cited by 18

The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation

White, E. E., & Rhodes, S. D. (2024) · Cancers · doi:10.3390/cancers16050994 · Cited by 19

Heat Hyperalgesia and Mechanical Hypersensitivity Induced by Calcitonin Gene-Related Peptide in a Mouse Model of Neurofibromatosis

White, S., de Prado, B. M., Russo, A. F., & Hammond, D. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106767 · Cited by 18

CELL CYCLE CONTROL IN THE TERMINALLY DIFFERENTIATED MYOCYTE

Williams, R. S. (1998) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70048-5 · Cited by 18

Ras/ MAPK dysregulation in development causes a skeletal myopathy in an activating BrafL597V mouse model for cardio‐facio‐cutaneous syndrome

Maeda, Y., Tidyman, W. E., Ander, B. P., Pritchard, C. A., & Rauen, K. A. (2021) · Developmental Dynamics · doi:10.1002/dvdy.309 · Cited by 17

Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis

Malminen, M., Peltonen, S. A., Koivunen, J. P., & Peltonen, J. T. K. (2002) · BMC Dermatology · doi:10.1186/1471-5945-2-10 · Cited by 17

Neurofibromatosis 1 - Mutant microglia exhibit sexually-dimorphic cyclic AMP-dependent purinergic defects

Elmadany, N., Logiacco, F., Buonfiglioli, A., Haage, V. C., Wright-Jin, E. C., Schattenberg, A., Papawassiliou, R. M., Kettenmann, H., Semtner, M., & Gutmann, D. H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105030 · Cited by 16

Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy

Liu, Y. L., Yan, Y., Webster, C., Shao, L., Lensing, S., Ni, H., Feng, W., Colorado, N. C., Pathak, R., Xiang, Z., et al. (2016) · Blood · doi:10.1182/blood-2015-05-646216 · Cited by 17

Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency

Sachs, Z., Been, R. A., DeCoursin, K. J., Nguyen, H. T., Hassan, N. A. M., Noble-Orcutt, K. E., Eckfeldt, C. E., Pomeroy, E. J., Díaz-Flores, E., Geurts, J. L., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.136002 · Cited by 17

Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin

Kim, T. J., Cariappa, A., Iacomini, J., Tang, M., Shih, S., Bernards, A., Jacks, T., & Pillai, S. S. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(01)00101-8 · Cited by 17

Developmental regulation of NF1 tumor suppressor gene in human peripheral nerve

Hirvonen, O., Lakkakorpi, J., Aaltonen, V., Hirvonen, H., Rossi, M., Karvonen, S. L., Ylä‐Outinen, H., Kalimo, H., & Peltonen, J. T. K. (1998) · Journal of Neurocytology · doi:10.1023/a:1006905224474 · Cited by 17

Neural Crest Migration and Mouse Models of Congenital Heart DiseasePreprint

Gitler, A. D., BROWN, C. B., Kochilas, L. K., LI, J., & Epstein, J. A. (2002) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2002.67.57 · Cited by 17

Targeting NF2-Hippo/Yap signaling pathway for cardioprotection after ischemia/reperfusion injury

Mia, M. M., Chelakkot-Govindalayathil, A.-L., & Singh, M. K. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.11.85 · Cited by 16

Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma

Brossier, N. M., Thondapu, S., Cobb, O. M., Dahiya, S. M., & Gutmann, D. H. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa237 · Cited by 16

Haptoglobin genotype as a risk factor for postmenopausal osteoporosis

Pescarmona, G., D’Amelio, P., Morra, E., & Isaia, G. C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.636 · Cited by 16

Modeling Neurofibromatosis Type 1 Tumors in the Mouse for Therapeutic InterventionPreprint

Parada, L. F., Kwon, C. H., & Zhu, Y. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.025 · Cited by 16

A new era for myelin research in N eurofibromatosis type 1

de Blank, P. M. K., Nishiyama, A., & López‐Juárez, A. (2023) · Glia · doi:10.1002/glia.24432 · Cited by 13

RAS/MEK–Independent Gene Expression Reveals BMP2-Related Malignant Phenotypes in the Nf1 -Deficient MPNST

Sun, D., Haddad, R., Kraniak, J. M., Horne, S. D., & Tainsky, M. A. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0593 · Cited by 15

Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1

Tritz, R., Benson, T. W., Harris, V. K., Hudson, F. Z., MINTZ, J. D., Zhang, H., Kennard, S., Chen, W., Stepp, D. W., Csányi, G., et al. (2020) · Translational research · doi:10.1016/j.trsl.2020.08.001 · Cited by 15

Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation

Costa, A. D. A., Chatterjee, J., Cobb, O. M., Cordell, E., Chao, A., Schaeffer, S., Goldstein, A. K., Dahiya, S. M., & Gutmann, D. H. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab194 · Cited by 15

Interstitial deletion of chromosome 11 (q22.3-q23.2) in a boy with mild developmental delay

Syrrou, M., & Fryns, J.-P. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.621 · Cited by 15

The effect of apamin, a small conductance calcium activated potassium (SK) channel blocker, on a mouse model of neurofibromatosis 1

Kallarackal, A. J., Simard, J. M., & Bailey, A. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.009 · Cited by 15

Regulating Heart Development: The Role ofNf1

Gitler, A. D., & Epstein, J. A. (2003) · Cell Cycle · doi:10.4161/cc.2.2.299 · Cited by 10

Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos

Yzaguirre, A. D., Padmanabhan, A., de Groh, E. D., Engleka, K. A., Li, J., Speck, N. A., & Epstein, J. A. (2015) · eLife · doi:10.7554/elife.07780 · Cited by 19

The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1-/- mice

Ismat, F. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28341 · Cited by 55

CREATING A MOUSE MODEL OF NEUROFIBROMATOSIS TYPE I:

Shih, T. S., & Jacks, T. (2016)

Nf1 has an essential role in endothelial cells

Gitler, A. D., Zhu, Y., Ismat, F. A., Lu, M. M., Yamauchi, Y., Parada, L. F., & Epstein, J. A. (2002) · Nature Genetics · doi:10.1038/ng1059 · Cited by 173